Michael Otto
President en Mjo Consulting LLC .
Fortuna: - $ al 31/03/2024
Perfil
Michael J.
Otto is currently the Director at Eleison Pharmaceuticals, Inc. and the President at Mjo Consulting LLC.
He previously worked as the Associate Director at Rhone-Poulenc Rorer Pharmaceuticals, Inc., Research Manager at DuPont Pharmaceuticals Co., Vice President-Research & Development at Avid Therapeutics, Inc., and Chief Scientific Officer at Pharmasset, Inc. He also served as an Independent Director at ContraFect Corp.
from 2014 to 2023.
Dr. Otto holds an undergraduate degree from Loyola University of Chicago and a doctorate from The Medical College of Wisconsin, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CONTRAFECT CORP.
0.00% | 06/09/2023 | 10 ( 0.00% ) | 0 $ | 31/03/2024 |
Cargos activos de Michael Otto
| Empresas | Cargo | Inicio |
|---|---|---|
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Director/Board Member | 01/01/2019 |
| Mjo Consulting LLC | President | 01/01/2019 |
Antiguos cargos conocidos de Michael Otto.
| Empresas | Cargo | Fin |
|---|---|---|
| CONTRAFECT CORPORATION | Director/Board Member | 04/12/2023 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 13/01/2012 |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/09/1999 |
| Avid Therapeutics, Inc. | Chief Tech/Sci/R&D Officer | 01/01/1997 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 01/01/1994 |
Formación de Michael Otto.
| Loyola University of Chicago | Undergraduate Degree |
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| Empresas privadas | 7 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
| Avid Therapeutics, Inc. | |
| Mjo Consulting LLC | |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Otto
